Antianthra APS
Records under this name other than patents Antianthra APS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Antianthra APS
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,727,253 | Treatment of accidental extravasation of anthracyclines Formerly held Term ended Term ended Mar 13, 2020 · USPTO record | Term ended | Term ended Mar 13, 2020 | USPTO record |
| US 6,265,385 | Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy Formerly held Term ended Term ended Mar 8, 2019 · USPTO record | Term ended | Term ended Mar 8, 2019 | USPTO record |